Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|
Total Revenue | 9,390 | -- | 9,305 | 7,043 |
Cost of Revenue | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- |
Operating Expenses | ||||
Research Development | -- | -- | -- | -- |
Selling General and Administrative | 5,022 | 2,845 | 5,743 | 3,949 |
Non Recurring | -- | -- | -- | -- |
Others | (5,022) | 4,827 | (5,743) | (3,949) |
Total Operating Expenses | -- | 7,672 | -- | -- |
Operating Income or Loss | -- | (7,672) | -- | -- |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | -- | (2,317) | -- | -- |
Earnings Before Interest And Taxes | -- | 1,209 | -- | -- |
Interest Expense | 1,860 | -- | 795 | 1,705 |
Income Before Tax | 683 | 159 | 2,414 | (1,177) |
Income Tax Expense | 81 | (21) | 487 | (474) |
Minority Interest | -- | -- | -- | -- |
Net Income From Continuing Ops | 1,408 | 180 | 1,927 | (703) |
Non-recurring Events | ||||
Discontinued Operations | -- | 375 | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | (806) | (375) | 0 | 0 |
Net Income | 602 | 180 | 1,927 | (703) |
Preferred Stock And Other Adjustments | -- | -- | -- | -- |
Net Income Applicable To Common Shares | 602 | 180 | 1,927 | (703) |